Pediatric transplantationHumansRituximabGraft RejectionPulmonary EdemaAntibodies
Severe Flash Pulmonary Edema Following Rituximab and Daratumumab Infusion for Post-Transplant Antibody-Mediated Rejection.
Zeynab Rajabi, Nahir Cortes-Santiago, Ivanna Maxson, Sameer Thadani, Maria C Gazzaneo, Saleh Bhar
Published: 202510.1111/petr.70230
Abstract
BACKGROUND: Monoclonal antibodies, including rituximab and daratumumab, play a pivotal role in the management of antibody-mediated rejection (AMR) following solid organ transplantation. Although generally effective, these agents can induce rare but p…
Preview only. Read the full abstract at the source